Beta-blockers will continue to fall out of favour for hypertension

January 2013

Beta-blockers will continue to fall out of favour for hypertension...especially atenolol.

Beta-blockers seem to prevent fewer CV events in patients with hypertension than other BP meds...despite similar BP lowering.

Atenolol has a particularly bad reputation...because most hypertension trials evaluating cardiovascular risk used atenolol.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Drug Interactions more alerts for drug and grapefruit interactions
Women's Health Divigel (estradiol) will be another transdermal option for women with menopausal symptoms
OTC Products new warnings about the potential dangers of energy drinks and "shots"
Dermatology tighter prescribing restrictions for ORAL isotretinoin (Accutane, Clarus) for women of childbearing age
Cardiology Beta-blockers will continue to fall out of favour for hypertension
Antithrombotics when to stop antiplatelet drugs or anticoagulants before surgery
Benzodiazepines Is it okay to COMBINE benzodiazepines
Psychiatry more use of corticosteroids and less use of antivirals to treat Bell's palsy
COPD new inhaled bronchodilator for COPD called Seebri Breezhaler (SEA-bree, glycopyrronium)
Aspirin Aspirin will be used to PREVENT recurrent venous thromboembolism
Oral Health what works for canker sores or aphthous ulcers